What Is Hindsight Bias In Investing?
You’ve probably heard the expression “hindsight is 20/20.” That saying…
Sell
28
EVAX Quote, Financials, Valuation and Earnings
Last price:
$1.77
Seasonality move
:
-12.33%
Day range:
$1.67 - $1.85
52-week range:
$1.67 - $22.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.49x
P/B ratio:
148.20x
Volume:
100.1K
Avg. volume:
177.1K
1-year change:
-88.71%
Market cap:
$11M
Revenue:
$73K
EPS (TTM):
-$2.80
Earnings Data
Next earnings date for EVAX
Mar 27
2025
Most recent earnings per share
-$2.00
Missed by $1.88
(Oct 31/2024)
Consensus Estimate
-$0.12
(Oct 31/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
EVAX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | $3.2M | -- | -- | -$0.65 | -- |
| 03/27/2025 | Q4 | $1.7M | -- | -- | -$0.15 | -- |
| 10/31/2024 | Q3 | -- | $3M | -$2.00 | -$0.12 | -$1.88 |
| 08/14/2024 | Q2 | $52K | $154K | -$6.00 | -$3.50 | -$2.50 |
| 05/28/2024 | Q1 | -- | $51K | $1.50 | -$4.95 | $6.45 |
| 03/27/2024 | Q4 | -- | $73K | -$7.50 | -$8.00 | $0.50 |
| 12/19/2023 | Q3 | -- | -- | -$10.50 | -$9.75 | -$0.75 |
| 08/18/2023 | Q2 | -- | -- | -$10.50 | -$10.75 | $0.25 |
| 05/31/2023 | Q1 | -- | -- | -$12.00 | -$12.00 | -- |
| 03/22/2023 | Q4 | -- | -- | -$14.50 | -$13.17 | -$1.33 |
| 11/14/2022 | Q3 | -- | -- | -$12.00 | -$13.33 | $1.33 |
| 08/10/2022 | Q2 | -- | -- | -$10.00 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$12.50 | -- | -- |
| 03/22/2022 | Q4 | -- | -- | -$19.50 | -- | -- |
| 11/09/2021 | Q3 | -- | -- | -$13.50 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$18.00 | -- | -- |
| 05/13/2021 | Q1 | -- | -- | -$11.50 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$13.18 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$12.38 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$9.48 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$8.07 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$9.16 | -- | -- |
Evaxion Biotech AS Earnings Questions
-
How Much did Evaxion Biotech AS Generate in Revenue Last Quarter?
Evaxion Biotech AS reported $3M worth of top line sales in its most recent quarter.
-
Did Evaxion Biotech AS Beat Earnings Last Quarter?
Evaxion Biotech AS announced earnings per share of -$2.00 which represents a miss of analyst forecast a -$0.12 per share.
-
Is Evaxion Biotech AS Profitable?
Evaxion Biotech AS reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Evaxion Biotech AS EPS Next Year?
Evaxion Biotech AS's earnings are forecast to decrease from -$8.10 per share to -$0.75 per share next year representing a decrease of -98.14%.
-
When is Evaxion Biotech AS's Earnings Date?
Evaxion Biotech AS's next earnings date is March 27, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Rivian a Good Stock a Buy?
Rivian Automotive (RIVN) had an initial IPO of close to…
Will Chevron Acquire Hess?
Long-time Buffett favorite in the energy sector Chevron (NYSE:CVX) is…
Stock Ideas
Buy
58
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
29
UNF alert for Mar 26
UniFirst [UNF] is up 1.54% over the past day.
Sell
30
KEQU alert for Mar 26
Kewaunee Scientific [KEQU] is down 3.3% over the past day.
Buy
82
EPAC alert for Mar 26
Enerpac Tool Group [EPAC] is down 2.32% over the past day.
